• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

JAMA PATIENT PAGE. Treatment of Liver Cancer.

作者信息

Mokdad Ali A, Singal Amit G, Yopp Adam C

出版信息

JAMA. 2016 Jan 5;315(1):100. doi: 10.1001/jama.2015.15431.

DOI:10.1001/jama.2015.15431
PMID:26746473
Abstract
摘要

相似文献

1
JAMA PATIENT PAGE. Treatment of Liver Cancer.《美国医学会杂志》患者专页。肝癌的治疗
JAMA. 2016 Jan 5;315(1):100. doi: 10.1001/jama.2015.15431.
2
Liver tumors and loco-regional therapy.肝脏肿瘤与局部区域治疗。
Wien Med Wochenschr. 2013 Mar;163(5-6):107-8. doi: 10.1007/s10354-013-0188-2.
3
[Resection or interventional treatment of hepatocellular carcinoma: which method for which patient?].[肝细胞癌的切除术或介入治疗：哪种方法适用于哪种患者？]
Dtsch Med Wochenschr. 2013 Sep;138(36):1780-4. doi: 10.1055/s-0033-1343347. Epub 2013 Aug 13.
4
Management of hepatocellular carcinoma: an overview of major findings from meta-analyses.肝细胞癌的管理：荟萃分析主要发现概述
Oncotarget. 2016 Jun 7;7(23):34703-51. doi: 10.18632/oncotarget.9157.
5
Sorafenib in combination with transarterial chemoembolization for the treatment of hepatocellular carcinoma.索拉非尼联合经动脉化疗栓塞术治疗肝细胞癌。
Clin Adv Hematol Oncol. 2016 Aug;14(8):585-7.
6
Treatment of intermediate-stage hepatocellular carcinoma.中期肝细胞癌的治疗
Clin Adv Hematol Oncol. 2015 Aug;13(8):501-3.
7
Complete remission of advanced hepatocellular carcinoma by radiofrequency ablation after sorafenib therapy.索拉非尼治疗后经射频消融实现晚期肝细胞癌完全缓解
World J Gastroenterol. 2015 Feb 28;21(8):2568-72. doi: 10.3748/wjg.v21.i8.2568.
8
The emerging questionable benefit of sorafenib as a neo-adjuvant in HCC patients treated with Y-90 radioembolization pending liver transplantation.对于等待肝移植且接受钇-90放射性栓塞治疗的肝癌患者，索拉非尼作为新辅助治疗的益处存疑。
J Hepatol. 2014 Aug;61(2):190-2. doi: 10.1016/j.jhep.2014.05.012. Epub 2014 May 15.
9
Managing localized unresectable hepatocellular carcinoma.局部不可切除肝细胞癌的管理
JAAPA. 2015 Jan;28(1):27-34. doi: 10.1097/01.JAA.0000458854.46279.d8.
10
Multidisciplinary Approach in Hepatocellular Carcinoma in a Level II Hospital: The First Decade of Hospital Universitario Fundacion Alcorcon.二级医院肝细胞癌的多学科治疗方法：阿尔科孔大学基金会医院的首个十年
Hepatogastroenterology. 2015 Jun;62(140):971-7.

引用本文的文献

1
The effect of perioperative probiotics and synbiotics on postoperative infections in patients undergoing major liver surgery: a meta-analysis of randomized controlled trials.围手术期益生菌和合生元对接受大肝手术患者术后感染的影响：一项随机对照试验的荟萃分析。
PeerJ. 2025 Feb 17;13:e18874. doi: 10.7717/peerj.18874. eCollection 2025.
2
Tc/Y radiolabeled biodegradable gel microspheres for lung shutting fraction assessment and radioembolization in hepatocellular carcinoma theranostics.用于肝细胞癌诊疗中肺分流分数评估及放射性栓塞的锝/钇放射性标记可生物降解凝胶微球
Mater Today Bio. 2024 Nov 27;29:101367. doi: 10.1016/j.mtbio.2024.101367. eCollection 2024 Dec.
3
A Lipiodol Pickering Emulsion Stabilized by Iron-Doped Carbon Nanozymes for Liver Transarterial Chemoembolization.
一种由铁掺杂碳纳米酶稳定的碘油皮克林乳液用于肝动脉化疗栓塞术
Adv Sci (Weinh). 2025 Feb;12(5):e2410873. doi: 10.1002/advs.202410873. Epub 2024 Dec 10.
4
Identification of PPAR-related differentially expressed genes liver hepatocellular carcinoma and construction of a prognostic model based on data analysis and molecular docking.基于数据分析和分子对接鉴定与过氧化物酶体增殖物激活受体（PPAR）相关的肝癌差异表达基因并构建预后模型
J Cell Mol Med. 2024 Apr;28(8):e18304. doi: 10.1111/jcmm.18304.
5
Icariin as a potential anticancer agent: a review of its biological effects on various cancers.淫羊藿苷作为一种潜在的抗癌剂：其对各种癌症的生物学效应综述
Front Pharmacol. 2023 Jun 30;14:1216363. doi: 10.3389/fphar.2023.1216363. eCollection 2023.
6
Advances in Nanoliposomes for the Diagnosis and Treatment of Liver Cancer.纳米脂质体在肝癌诊断和治疗中的研究进展。
Int J Nanomedicine. 2022 Feb 26;17:909-925. doi: 10.2147/IJN.S349426. eCollection 2022.
7
Heterogeneities of Site-Specific -Glycosylation in HCC Tumors With Low and High AFP Concentrations.甲胎蛋白浓度低和高的肝癌肿瘤中位点特异性N-糖基化的异质性
Front Oncol. 2020 Apr 21;10:496. doi: 10.3389/fonc.2020.00496. eCollection 2020.
8
Anisodamine Suppressed the Growth of Hepatocellular Carcinoma Cells, Induced Apoptosis and Regulated the Levels of Inflammatory Factors by Inhibiting NLRP3 Inflammasome Activation.山莨菪碱通过抑制 NLRP3 炎性小体的激活抑制肝癌细胞生长、诱导细胞凋亡并调节炎症因子水平。
Drug Des Devel Ther. 2020 Apr 29;14:1609-1620. doi: 10.2147/DDDT.S243383. eCollection 2020.
9
Significance of incorporation of DNMT1 and HLA-DRα with TNM staging in patients with hepatocellular carcinoma after curative resection.根治性切除术后肝细胞癌患者中DNMT1和HLA-DRα与TNM分期结合的意义
Int J Clin Exp Pathol. 2017 Sep 1;10(9):9372-9381. eCollection 2017.
10
Short-term Outcomes of Laparoscopic vs. Open Hepatectomy for Primary Hepatocellular Carcinoma: A Prospective Comparative Study.腹腔镜与开腹肝切除术治疗原发性肝细胞癌的短期疗效比较：一项前瞻性对照研究。
Curr Med Sci. 2019 Oct;39(5):778-783. doi: 10.1007/s11596-019-2105-4. Epub 2019 Oct 14.